Technology

Tackling the Unmet Clinical Need

Our Technology

  • Advanced Diagnostic Solution: The iKOr™ microcatheter system enables cardiologists to accurately diagnose complex heart conditions.
  • Simple and Intuitive: Easy to use with minimal training, ensuring rapid adoption and efficient operation.
  • Designed for the Cath Lab: Seamlessly integrates into existing cath lab workflows, enhancing efficiency without disrupting routine procedures.
  • Complete Physiological Profile: Provides a comprehensive physiological profile to guide precise clinical decisions.
  • Data-Driven Care: Empowers cardiologists with real-time, actionable data to direct patients to the most appropriate therapy.

Addressing gender bias

  • Closing the Gender Gap in Heart Health: Committed to addressing the underdiagnosis of cardiovascular diseases in women, who are 5x more likely to suffer from conditions like ANOCA.
  • Backed by Clinical Evidence: Our approach is guided by clinical evidence showing that women often present with different symptoms and require specialized diagnostic insights for accurate detection.
  • Guided by Research Insights: Aligned with the McKinsey report on healthcare equity, we are dedicated to improving diagnostic accuracy and health outcomes for women.
  • Enhanced Clinical Decision-Making: The iKOr™ microcatheter system provides comprehensive physiological data, empowering clinicians with detailed insights to make better-informed treatment decisions for women.
  • Advancing Health Equity: We are pioneering a new standard in cardiovascular care by bridging the gap in diagnosis and empowering clinicians to make informed decisions that improve women’s heart health.

Clinical Evidence

  • Superior Accuracy and Precision:
    Current CFR measurement methods (e.g., bolus/thermodilution) have 30% variability and poor reproducibility.
  • iKOr™ system demonstrates superior accuracy in preclinical testing, potentially offering significantly more reliable diagnostics.
  • Enhanced Diagnostic Efficiency:
    Rapid-Exchange Microcatheter design allows use with a workhorse guidewire, reducing procedural time and complexity.
  • Enables quick, sequential readings before and after interventions without removing and reinserting guidewires.

Comprehensive Physiological Profile:

  • Measures CFRIMRdiastolic flow indices, and continuous relative flow and resistance data, providing a complete coronary physiology assessment.
  • This robust dataset allows for better differentiation of ANOCA etiologies such as microvascular dysfunction and coronary spasm.

Guiding Better Treatment Decisions:

  • Data from studies like CorMicA and ChaMP-CMD show that accurate stratification using advanced metrics improves patient outcomes by guiding more targeted therapies.

Patient Impact

Further Information

Heart disease affects women differently, often leading to misdiagnosis or delayed treatment. The iKOr™ system closes this gap by providing a complete coronary physiology profile, allowing cardiologists to accurately identify complex conditions like ANOCA. This means fewer unnecessary procedures, faster diagnosis, and personalized therapy plans that truly address the underlying cause of symptoms.